RecruitingNCT07397689

Early Sepsis Recognition Tool

Sepsis Optimal Recognition Toolkit in Children (SORT): An Early Recognition Tool for Children in Asia


Sponsor

KK Women's and Children's Hospital

Enrollment

40,000 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study seeks to develop early recognition tools specially designed for children meeting the Phoenix definition and explore implementation science aspects by investigating facilitators and barriers to adopting Phoenix sepsis criteria in clinical practice. This addresses the critical need for systemic, evidence-based approaches to paediatric sepsis identification across diverse healthcare settings in Asia.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Application of the Phoenix Sepsis Score for people with infection and sepsis. The study is currently recruiting participants at 19 locations. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERApplication of the Phoenix Sepsis Score

Data Variables in the first 24 hours of hospital admission as per Phoenix Sepsis Score: Including that of respiratory function (PaO2:FiO2 and SpO2:FiO2 ratios, need for oxygen, high-flow, non-invasive or mechanical ventilation support), cardiovascular function (including need for vasoactive medications, lactate value and mean arterial pressure), coagulopathy (measured using platelets, International Normalized Ratio, D-dimer and Fibrinogen), neurologic dysfunction (measured with Glasgow Coma Scale and presence of fixed pupils), endocrine (blood glucose), immunologic (absolute neutrophil and absolute lymphocyte count), renal (creatinine levels) and hepatic (total bilirubin and alanine transaminase). Data from the Emergency Departments will need to be linked to inpatient records to obtain the worst values in each domain that occurred in the first 24 hours.


Locations(19)

Shanghai Children's Medical Center, Shanghai Jiaotong University

Shanghai, China

Prince of Wales Hospital, The Chinese University of Hong Kong

Hong Kong, Hong Kong

Hospital Pulau Pinang

George Town, Malaysia

Hospital Sultanah Aminah Johor Bahru

Johor Bahru, Malaysia

Hospital Tengku Ampuan Rahimah

Klang, Malaysia

Hospital Tunku Azizah (Hospital Wanita dan Kanak-Kanak Kuala Lumpur)

Kuala Lumpur, Malaysia

UKM: Hospital Tunku Ampuan Besar Tuanku Aishah Rohani

Kuala Lumpur, Malaysia

University Malaya Medical Centre (UMMC)

Kuala Lumpur, Malaysia

Hospital Umum Sarawak

Kuching, Malaysia

Hospital Sultan Idris Shah

Serdang, Malaysia

Aga Khan University

Karachi, Pakistan

King Abdullah Specialist Children's Hospital

Riyadh, Saudi Arabia

KK Women's and Children' Hospital

Singapore, Singapore

National University Hospital

Singapore, Singapore

Chang Gong Memorial Hospital

Taipei, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

Ramathibodi Hospital, Mahidol University

Bangkok, Thailand

The National Children's Hospital

Hanoi, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07397689


Related Trials